16/11/2017 - 10:10 StockMarketWire
Jefferies International today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price ta...
16/11/2017 - 07:00 RNS
RNS Number: 6797W GlaxoSmithKline PLC 16 November 2017 Issued: 16 November 2017, London UK - LSE Announcement Trelegy Ellipta once-daily single inhaler triple therapy gains marketing authorisation in Europe for the treatment of COPD GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the European Co...
10/11/2017 - 13:15 RNS
RNS Number: 2011W GlaxoSmithKline PLC 10 November 2017 GlaxoSmithKline plc (the ' Company ') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Ms E Walmsley b) Position/status Chief Executive Officer c) Initial notification/ amendment Initial notification 2. Details of the issuer, emission allowance market partic...
09/11/2017 - 17:00 RNS
RNS Number: 1021W GlaxoSmithKline PLC 09 November 2017 BLOCK LISTING SIX MONTHLY RETURN Information provided on this form must be typed or printed electronically and provided to an ris . Date: 09 November 2017 Name of applicant: GlaxoSmithKline plc Name of scheme: GlaxoSmithKline Share Option Plan - Ordinary Shares Period of return: F...
Join interactive investor
- £22.50 fixed quarterly charge includes £22.50 in trading credits
- £10 per trade or £6 for frequent traders
- No % platform fees
- £1 per trade for regular investment or dividend reinvestment